Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Arnarsdottir, Lola ^a   Hjalmarsson, Clara ^a   Bokemark, Lena ^a   Andersson, Björn ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiplatelet; Mortality; Post stroke; Pre stroke; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; WARFARIN;

AGED; ARTICLE; BRAIN ISCHEMIA; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HOSPITAL CARE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; SURVIVAL;

AGED; ASPIRIN; BRAIN ISCHEMIA; COMORBIDITY; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PREVALENCE; STROKE; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN; TREATMENT OUTCOME;

EID: 84867954414     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-67     Document Type: Article

References (22)

1. Wilterdink JL, Bendixen B, Adams HP, Woolson RF, Clarke WR, Hansen MD, . MS; for the TOAST Investigators Effect of prior aspirin use on stroke severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke 2001, 32:2836-2840. 10.1161/hs1201.099384, 11739983, MS; for the TOAST Investigators.
2. Sanossian N, Saver JL, Rajajee V, Selco SL, Kim D, Razinia T, Obviagele B. Premorbid antiplatelet use and ischemic stroke outcomes. Neurology 2006, 66:319-323. 10.1212/01.wnl.0000195889.05792.f1, 16382033.
3. Kalra L, Perez I, Smithard DG, Sulch D. Does prior use of aspirin affect outcome in ischemic Stroke?. Am J Med 2000, 108:205-209. 10.1016/S0002-9343(99)00431-3, 10723974.
4. Ricci SR, Lewis S, Sandercock P, . on behalf of the IST Collaborative Group Previous use of aspirin and baseline stroke severity. An analysis of 17 850 patients in the International Stroke Trial. Stroke 2006, 37:1737-1740. 10.1161/01.STR.0000226740.29910.91, 16741185, on behalf of the IST Collaborative Group.
5. Greisenegger S, Tentschert S, Weber M, Ferrari J, Lang W, Lalouschek W. Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischemic stroke/TIA. J Neurol 2006, 253:648-652. 10.1007/s00415-006-0088-0, 16619118.
6. Paciaroni M, Agnelli G, Caso V, Venti M, Alberti A, Milia P, Silvestrelli G, Biagini S. Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke. J Thromb Haemostat 2006, 4:1957-1961.
7. dÈsterre CD, Lee T-Y. Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits. Ann NY Acad Sci 2010, 1207:71-75. 10.1111/j.1749-6632.2010.05801.x, 20955428.
8. The ESPRIT Study Group Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006, 367:1665-1673. The ESPRIT Study Group.
9. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowethal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996, 143:1-13. 10.1016/S0022-510X(96)00308-5, 8981292.
10. Dowlatshahi D, Hakim A, Fang J, Sharma M, . on behalf of the Investigators of the Registry of the Canadian Stroke Network Pre- admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network. Int J of Stroke 2009, 4:328-334. on behalf of the Investigators of the Registry of the Canadian Stroke Network.
11. Dippel DWJ, Maasland L, Halkes P, Kapelle LJ, Koudstaal PJ, Algra A, . on behalf of the ESPRIT Study Group and the ESPS-2 Investigators Prevention with low-dose aspirin plus dipyridamole in patients with disabling stroke. Stroke 2010, 41:2684-2686. 10.1161/STROKEAHA.110.586453, 20884870, on behalf of the ESPRIT Study Group and the ESPS-2 Investigators.
12. Chairangsarit P, Sithinamsuwan P, Niyasom S, Udommongkol C, Nidhhinandana S, Suwantamee J. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: A preliminary study. J Med Assoc Thai 2005, 88:S 148-154.
13. Leonardi-Bee J, Bath PM, Bousser MG, Davalos A, Diener HC, Guiraud-Chaumeil B, Sivenius J, Yatsu F, Dewey ME, . Dipyridamole in Stroke Colloboration (DISC) Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke 2005, 36:162-168. 10.1161/01.STR.0000149621.95215.ea, 15569877, Dipyridamole in Stroke Colloboration (DISC).
14. WHO MONICA. Project Principal Investigators The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988, 41:105-114. 10.1016/0895-4356(88)90084-4, 3335877, WHO MONICA. Project Principal Investigators.
15. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 46:660-662.
16. König IR, Ziegler A, Bluhmki E, Hacke W, Bath PMW, Sacco RL, Diener HC. Weimar; on behalf of the Virtual International Stroke Trials Archive (VISTA) Investigators: Predicting long-term outcome after acute ischemic stroke. A simple index works in patients from controlled clinical trials. Stroke 2008, 39:1821-1826. 10.1161/STROKEAHA.107.505867, 18403738.
17. Adams HP, Bendixen BH, Kapelle LJ, Biller J, Love BB, Gordon DL, Marsh E, . the TOAST Investigators Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial. Stroke 1993, 24:35-41. 10.1161/01.STR.24.1.35, 7678184, the TOAST Investigators.
18. Bonita R, Beaglehole R. Modification of Rankin Scale: recovery of motor function after stroke. Stroke 1988, 12:1497-1500.
19. Eriksson M, Appelros P, Norrving B, Terént A, Stegmayr B. Assessment of functional outcome in a national quality register for acute stroke. Can simple self-reported items be transformed into the Modified Rankin Scale?. Stroke 2007, 38:1384-1386. 10.1161/01.STR.0000260102.97954.9c, 17322093.
20. Wook-Joo K, Youngchai K, Mi Hwa Y, Sun-Hye I, Jung Hyun P, Ji Sung L, Juneyoung L, Moon-Ku H, Hee-Joon B. Differential effect of previous antiplatelet use on stroke severity according to stroke mechanism. Stroke 2010, 41:1200-1204. 10.1161/STROKEAHA.110.580225, 20431078.
21. The American-Canadian Co-Operative Study Group Persantine aspirin trial in cerebral ischemia part II: Endpoint results. Stroke 1985, 16:406-415. The American-Canadian Co-Operative Study Group.
22. Asplund K, Glader EL, Norrving B, Eriksson M, . for the Riks-Stroke Collaboration Effects of extending the time window of thrombolysis to 4.5 hours. Observations in the Swedish Stroke Register (Riks-Stroke). Stroke 2011, 42:2492-2497. 10.1161/STROKEAHA.111.618587, 21799155, for the Riks-Stroke Collaboration.